WAVE LIFE SCIENCES LTD. Income Taxes Receivable, Current
WAVE LIFE SCIENCES LTD. (WVE) had Income Taxes Receivable, Current of $18.69 million as of 2020-03-31, per its 10-Q filed 2020-05-11.
Discontinued › Notes › Nontrade Receivables
us-gaap:IncomeTaxesReceivable · last filed 2020-05-11
- 2020-03-31: Income Taxes Receivable, Current $18.69M.
- 2019-12-31: Income Taxes Receivable, Current $8.21M.
| Period end | Income Taxes Receivable, Current |
|---|---|
| 2020-03-31 | $18.69M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $8.21M 10-Q · filed 2020-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |